What is the cost-effectiveness of intensive blood pressure management?
Richman et al. (2016) conducted a cost-effectiveness analysis of intensive blood pressure management in the US. They found that intensive blood pressure management was cost-effective in most patient subgroups, and dominated in subgroups with higher baseline risk. However, they also found that the cost-effectiveness of intensive blood pressure management was sensitive to changes in the cost of antihypertensive medications. Therefore, the cost-effectiveness of intensive blood pressure management should be assessed for each individual patient before implementing such an approach.